Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer.

Telli, M L; Stover, D G; Loi, S; Aparicio, S; Carey, L A; Domchek, S M; Newman, L; Sledge, G W; Winer, E P

Telli, M L; Stover, D G; Loi, S; Aparicio, S; Carey, L A; Domchek, S M; Newman, L; Sledge, G W; Winer, E P.

Affiliation

Telli ML; Stanford University School of Medicine, Stanford, CA, USA.
Stover DG; Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. daniel.stover@osumc.edu.
Loi S; Ohio State University Comprehensive Cancer Center, Biomedical Research Tower, Room 512, 460 West 12th Ave, Columbus, OH, 43210, USA. daniel.stover@osumc.edu.
Aparicio S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Carey LA; University of British Columbia, Vancouver, BC, Canada.
Domchek SM; University of North Carolina, Chapel Hill, NC, USA.
Newman L; University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Sledge GW; Henry Ford Hospital, Detroit, MI, USA.
Winer EP; Stanford University School of Medicine, Stanford, CA, USA.

Breast Cancer Res Treat ; 171(1): 21-31, 2018 Aug.

Article de En | MEDLINE | ID: mdl-29736741

Sujet(s)
Mots clés

DNA damage; Homologous recombination deficiency; Triple-negative breast cancer; Tumor immunity

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Recombinaison homologue / Tumeurs du sein triple-négatives / Immunité Limites: Animals / Female / Humans Langue: En Journal: Breast Cancer Res Treat Année: 2018 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google